241 related articles for article (PubMed ID: 3957488)
21. Digoxin-quinidine interaction Pharmacokinetic evaluation.
Hager WD; Fenster P; Mayersohn M; Perrier D; Graves P; Marcus FI; Goldman S
N Engl J Med; 1979 May; 300(22):1238-41. PubMed ID: 431681
[TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacokinetics of theophylline during co-treatment with cefaclor.
Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Hempenius J
Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):88-92. PubMed ID: 3957498
[TBL] [Abstract][Full Text] [Related]
23. Rosiglitazone has no clinically significant effect on nifedipine pharmacokinetics.
Harris RZ; Inglis AM; Miller AK; Thompson KA; Finnerty D; Patterson S; Jorkasky DK; Freed MI
J Clin Pharmacol; 1999 Nov; 39(11):1189-94. PubMed ID: 10579151
[TBL] [Abstract][Full Text] [Related]
24. Effects of long-term oral carvedilol on the steady-state pharmacokinetics of oral digoxin in patients with mild to moderate hypertension.
Wermeling DP; Field CJ; Smith DA; Chandler MH; Clifton GD; Boyle DA
Pharmacotherapy; 1994; 14(5):600-6. PubMed ID: 7997394
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
[TBL] [Abstract][Full Text] [Related]
27. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
28. Digoxin disposition kinetics in dogs before and during azotemia.
Gierke KD; Perrier D; Mayersohn M; Marcus FI
J Pharmacol Exp Ther; 1978 May; 205(2):459-64. PubMed ID: 641840
[TBL] [Abstract][Full Text] [Related]
29. Estimation of pharmacokinetic parameters of digoxin from serum, saliva and urine.
Allonen H; Iisalo E; Kangas L; Lammintausta R; Salonen M
Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):420-3. PubMed ID: 700915
[TBL] [Abstract][Full Text] [Related]
30. A study of the potential pharmacokinetic interaction of lisinopril and digoxin in normal volunteers.
Vandenburg MJ; Morris F; Marks C; Kelly JG; Dews IM; Stephens JD
Xenobiotica; 1988 Oct; 18(10):1179-84. PubMed ID: 2853897
[TBL] [Abstract][Full Text] [Related]
31. Nifedipine serum concentrations following sublingual and oral doses.
Brown GR; Fraser DG; Castile JA; Gaudreault P; Platt DR; Friedman PA
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):283-6. PubMed ID: 3733277
[TBL] [Abstract][Full Text] [Related]
32. Age dependant factors influencing digoxin pharmacokinetics in the postnatal puppy.
Singh S; Gadgil S; Mirkin BL
Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):87-101. PubMed ID: 684281
[TBL] [Abstract][Full Text] [Related]
33. Effect of nifedipine on digoxin kinetics in healthy subjects.
Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Kjaer K; Nielsen-Kudsk F
Clin Pharmacol Ther; 1982 Nov; 32(5):562-5. PubMed ID: 7127997
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of digoxin in the rat.
Harrison LI; Gibaldi M
Drug Metab Dispos; 1976; 4(1):88-93. PubMed ID: 3407
[TBL] [Abstract][Full Text] [Related]
35. Effect of nifedipine on serum digoxin concentration and renal digoxin clearance.
Schwartz JB; Migliore PJ
Clin Pharmacol Ther; 1984 Jul; 36(1):19-24. PubMed ID: 6734045
[TBL] [Abstract][Full Text] [Related]
36. Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanism and clinical implications.
Doering W
N Engl J Med; 1979 Aug; 301(8):400-4. PubMed ID: 460341
[TBL] [Abstract][Full Text] [Related]
37. Effects of quinidine, verapamil and nifedipine on the pharmacokinetics and pharmacodynamics of digitoxin during steady state conditions.
Kuhlmann J
Arzneimittelforschung; 1987 May; 37(5):545-8. PubMed ID: 3619976
[TBL] [Abstract][Full Text] [Related]
38. The pharmacokinetics of digoxin in patients with manifest hyperthyroidism and after normalization of thyroid function.
Bonelli J; Haydl H; Hruby K; Kaik G
Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):302-6. PubMed ID: 669876
[TBL] [Abstract][Full Text] [Related]
39. Dose-dependence of the nifedipine-digoxin interaction?
Kirch W; Hutt HJ; Dylewicz P; Gräf KJ; Ohnhaus EE
Clin Pharmacol Ther; 1986 Jan; 39(1):35-9. PubMed ID: 3943268
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of digoxin in the cat and comparisons with man and the dog.
Weidler DJ; Jallad NS; Movahhed HS; Sakmar E; Wagner JG
Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):57-66. PubMed ID: 625594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
